About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
AV-1451
AV-1451
- Company
- Mayo Clinic
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 13 recruiting
Efficacy results: Not yet reported
13 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 21, 2026
Find a Clinical Trial Near Me
See recruiting studies for AV-1451 and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT01818661
Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech
Not yet reported Mayo Clinic 50 participants Est. completion 2028-06 1 site Stand-aloneOther conditions: PPA, Non-fluent Aphasia, Apraxia of Speech, Primary Progressive Non-fluent Aphasia, Primary Progressive AphasiaView official trial listing → -
Recruiting NCT NCT02414347
F 18 T807 Tau PET Imaging of Alzheimer's Disease
Tammie L. S. Benzinger, MD, PhD 900 participants Est. completion 2026-12 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT02605785
A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
Not yet reported Mayo Clinic 332 participants Est. completion 2030-01 1 siteOther conditions: Progressive Supranuclear PalsyView official trial listing → -
Recruiting NCT NCT02740634
Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study
Not yet reported Mayo Clinic 60 participants Est. completion 2027-03 1 siteOther conditions: Atypical Alzheimer's Disease, Logopenic Progressive Aphasia (LPA), Posterior Cortical Atrophy (PCA), Alzheimer Disease, Alzheimer Disease, Early Onset, Amnestic Disorder, Amnestic Symptoms, Amnestic Mild Cognitive DisorderView official trial listing → -
Recruiting NCT NCT03143374
PET Tau - Neurodegenerative Disease Imaging
Not yet reported, Not yet reported University of Pennsylvania 300 participants Est. completion 2030-09 1 site Stand-aloneOther conditions: Neurodegenerative DiseaseView official trial listing → -
Recruiting NCT NCT03809351
UAB Alzheimer's Disease Center Core Cohort - Tau Imaging Substudy
Not yet reported University of Alabama at Birmingham 160 participants Est. completion 2028-07 1 site Stand-aloneOther conditions: Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT04150198
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 45 participants Est. completion 2029-12-31 2 sitesOther conditions: Alzheimer Disease, Early Onset, Posterior Cortical AtrophyView official trial listing → -
Recruiting NCT NCT04579120
Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)
Tammie L. S. Benzinger, MD, PhD 650 participants Est. completion 2027-12 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Recruiting NCT NCT04708613
University of Pittsburgh Brain Health Initiative
David Okonkwo, MD, PhD 300 participants Est. completion 2026-12 1 siteOther conditions: Traumatic Brain InjuryView official trial listing → -
Recruiting NCT NCT05446805
Depression and Driving
Washington University School of Medicine 150 participants Est. completion 2027-12-17 1 siteOther conditions: Depression, DriveView official trial listing → -
Recruiting NCT NCT05658913
Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
University of Pennsylvania 100 participants Est. completion 2029-12 2 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Recruiting NCT NCT06833645
[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease
Sichuan Provincial People's Hospital 280 participants Est. completion 2025-02-25 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Recruiting NCT NCT07000851
Imaging Studies in Corticobasal Syndrome
Jennifer Whitwell 80 participants Est. completion 2031-03-30 1 siteOther conditions: Cortico Basal Degeneration, Corticobasal Syndrome, Corticobasal Syndrome(CBS), Corticobasal Degeneration, Corticobasal Degeneration (CBD), Corticobasal Syndrome (CBS)View official trial listing → -
Enrolling by invitation NCT NCT00950430
Imaging of Brain Amyloid Plaques in the Aging Population
Not yet reported Mayo Clinic 8000 participants Est. completion 2027-06 1 site Stand-aloneOther conditions: Alzheimer's Disease, Dementia With Lewy Bodies, Frontotemporal Dementia, Vascular DementiaView official trial listing → -
Completed NCT NCT01231971
Alzheimer's Disease Neuroimaging Initiative 2
University of Southern California 1182 participants Est. completion 2017-11-29 58 sitesOther conditions: Mild Cognitive Impairment (MCI), Alzheimer's Disease (AD), Significant Memory Concern (SMC), Early Mild Cognitive Impairment (EMCI), Late Mild Cognitive Impairment (LMCI)View official trial listing → -
Completed NCT NCT01992380
A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects
Not yet reported Avid Radiopharmaceuticals 24 participants Est. completion 2014-05-30 2 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02016560
Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects
Not yet reported, Not yet reported Avid Radiopharmaceuticals 383 participants Est. completion 2017-07-28 27 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Terminated NCT NCT02051764
Imaging Characteristics of a Follow-up 18F-AV-1451 Scan
Not yet reported Avid Radiopharmaceuticals 44 participants Est. completion 2016-12 4 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02079766
18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy
Not yet reported Avid Radiopharmaceuticals 41 participants Est. completion 2015-10 2 sitesOther conditions: Chronic Traumatic EncephalopathyView official trial listing → -
Completed NCT NCT02167594
Tau Imaging in Subjects With Progressive Supranuclear Palsy, Corticobasal Degeneration and Healthy Volunteers
Not yet reported Avid Radiopharmaceuticals 29 participants Est. completion 2016-07-11 5 sitesOther conditions: Progressive Supranuclear Palsy, Corticobasal DegenerationView official trial listing → -
Completed NCT NCT02191267
Tau Imaging of Chronic Traumatic Encephalopathy
Not yet reported Brigham and Women's Hospital 30 participants Est. completion 2016-09-30 2 sitesOther conditions: Chronic Traumatic EncephalopathyView official trial listing → -
Completed NCT NCT02266563
Amyloid and Tauopathy PET Imaging in Acute and Chronic Traumatic Brain Injury
Samuel Gandy 46 participants Est. completion 2017-12-21 1 siteOther conditions: Traumatic Brain Injury, Chronic Traumatic Encephalopathy, Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT02278354
Tau Imaging in Professional Fighters
Not yet reported Avid Radiopharmaceuticals 35 participants Est. completion 2017-02-03 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02278367
Clinical Evaluation of Flortaucipir F 18
Not yet reported Avid Radiopharmaceuticals 179 participants Est. completion 2019-06-26 5 sitesOther conditions: Alzheimer's Disease, Traumatic Brain Injury, DepressionView official trial listing → -
Completed NCT NCT02289118
Tau Imaging in Young Onset Dementia
University of Pennsylvania 16 participants Est. completion 2019-01-31 1 siteOther conditions: Alzheimer's Disease, Early Onset, Logopenic Progressive Aphasia, Posterior Cortical Atrophy (PCA)View official trial listing → -
Completed NCT NCT02336360
Augmenting Flortaucipir Dosimetry Estimates
Not yet reported Avid Radiopharmaceuticals 6 participants Est. completion 2015-06 1 siteOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02350634
18F-AV-1451 High Resolution Autopsy Study
Not yet reported Avid Radiopharmaceuticals 3 participants Est. completion 2017-06-16 2 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Enrolling by invitation NCT NCT02414178
F 18 T807 Tau PET Imaging in Dominantly Inherited Alzheimer's Network (DIAN Project)
Washington University School of Medicine 130 participants Est. completion 2027-01 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT02414230
F 18 T807 Tau PET Imaging in Familial Amyotrophic Lateral Sclerosis
Tammie L. S. Benzinger, MD, PhD 9 participants Est. completion 2020-06-10 1 siteOther conditions: Amyotrophic Lateral Sclerosis (ALS)View official trial listing → -
Completed NCT NCT02414282
F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)
Tammie L. S. Benzinger, MD, PhD 20 participants Est. completion 2020-10-20 1 siteOther conditions: Alzheimer Disease, Progressive Posterior Cortical Dysfunction (PPCD)View official trial listing → -
Withdrawn NCT NCT02512029
18F-AV-1451 PET Imaging in TBI
Not yet reported Avid Radiopharmaceuticals Est. completion 2017-04 1 site Stand-aloneOther conditions: Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT02516046
18F-AV-1451 Autopsy Study
Not yet reported Avid Radiopharmaceuticals 156 participants Est. completion 2018-07-15 31 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02676843
Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations
Not yet reported Columbia University 7 participants Est. completion 2018-11-25 1 site Stand-aloneOther conditions: Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD), TauopathiesView official trial listing → -
Withdrawn NCT NCT02707978
F 18 T807 Tau PET Imaging of Frontotemporal Dementia (FTD)
Not yet reported Tammie L. S. Benzinger, MD, PhD Est. completion 2020-12-30 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT02736695
Assessment of Hyperphosphorylated Tau PET Binding in Primary Progressive Aphasia and Frontotemporal Dementia
Not yet reported Mayo Clinic 81 participants Est. completion 2024-08-01 1 siteOther conditions: Primary Progressive Aphasia, Behavioral Variant of Frontotemporal Dementia, Frontotemporal Dementia, Behavioral VariantView official trial listing → -
Completed NCT NCT02759887
Relationship Between Down Syndrome (DS) and Alzheimer's Disease (AD)
Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 19 participants Est. completion 2018-12 1 siteOther conditions: Down Syndrome, Alzheimer's DementiaView official trial listing → -
Terminated NCT NCT02791191
A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia
Not yet reported Eli Lilly and Company 316 participants Est. completion 2018-07-02 76 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02795780
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
Not yet reported Avid Radiopharmaceuticals 79 participants Est. completion 2017-08-28 22 sitesOther conditions: Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT02850146
18F-AV-1451 PET Imaging in Participants Enrolled in the LEARN Study
Not yet reported University of Southern California 55 participants Est. completion 2023-09-29 7 sites Stand-aloneOther conditions: Cognition DisordersView official trial listing → -
Active, not recruiting NCT NCT02958670
Imaging Tau Deposition in the Brain of Elderly Subjects
Not yet reported University of Zurich 141 participants Est. completion 2029-12 1 site Stand-aloneOther conditions: Mild Cognitive Impairment, Healthy, Alzheimer Disease, Neurocognitive DisordersView official trial listing → -
Completed NCT NCT03019536
A Study of LY3303560 in Participants With Mild Cognitive Impairment or Alzheimer's Disease
Not yet reported Eli Lilly and Company 22 participants Est. completion 2019-06-05 11 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT03040713
Flortaucipir PET Imaging in Subjects With FTD
Not yet reported Avid Radiopharmaceuticals 16 participants Est. completion 2018-10-24 3 sitesOther conditions: Frontotemporal DementiaView official trial listing → -
Terminated NCT NCT03052972
Flortaucipir 18F PET Imaging in BIOCARD Study
Not yet reported Avid Radiopharmaceuticals 23 participants Est. completion 2018-08-17 1 siteOther conditions: Cognitive DeclineView official trial listing → -
Active, not recruiting NCT NCT03189485
Tau PET Imaging in the NACC Study Cohort
University of Pennsylvania 106 participants Est. completion 2027-05-31 1 siteOther conditions: Normal Controls, MCIView official trial listing → -
Completed NCT NCT03279523
F 18 T807 PET (Positron Emission Tomograph )Scan for HIV Infected & Uninfected
Tammie L. S. Benzinger, MD, PhD 60 participants Est. completion 2018-05-23 1 siteOther conditions: Alzheimer Disease, HIVView official trial listing → -
Completed NCT NCT03283449
Tau PET Imaging in Atypical Dementias
Not yet reported University of Chicago 70 participants Est. completion 2025-02-28 1 site Stand-aloneOther conditions: Primary Progressive Aphasia With Suspected Alzheimer's DiseaseView official trial listing → -
Completed NCT NCT03287765
Evaluating the Relationship Between Tau PET Imaging and CSF Biomarkers of AD (Alzheimer Disease) in Humans
Tammie L. S. Benzinger, MD, PhD 54 participants Est. completion 2021-07-19 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT03322462
Tau Screening Study in Patients With Early Symptomatic AD
Not yet reported Avid Radiopharmaceuticals 155 participants Est. completion 2018-08-31 10 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT03467477
Tau Screening Study in Subjects With Early Symptomatic AD
Not yet reported Avid Radiopharmaceuticals 161 participants Est. completion 2018-11-15 9 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Active, not recruiting NCT NCT03507257
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Indiana University 850 participants Est. completion 2027-01-01 23 sitesOther conditions: Early Onset Alzheimer Disease, Alzheimer Disease, Mild Cognitive ImpairmentView official trial listing → -
Withdrawn NCT NCT03641768
Risk Prediction for Alzheimer Dementia With Brain Imaging and Genetics
Not yet reported Duke University Est. completion 2021-01-01 1 siteOther conditions: Alzheimer Dementia, Posttraumatic Stress Disorder, Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT03718494
Continuation of The Kronos Early Estrogen Prevention Study (KEEPS)
Mayo Clinic 299 participants Est. completion 2022-09-01 6 sitesOther conditions: Alzheimer DementiaView official trial listing → -
Withdrawn NCT NCT03816228
Imaging of Brain Structural/Functional Connectivity and Amyloid and Tau Lesions in APOE4 Carriers.
Tammie L. S. Benzinger, MD, PhD Est. completion 2022-10-11 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT03901092
A Reader Study to Assess Accuracy and Reliability of Flortaucipir F 18 Positron Emission Tomography (PET) Scan Interpretation
Not yet reported Avid Radiopharmaceuticals 242 participants Est. completion 2019-04-26 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Completed NCT NCT03901105
Evaluation of Flortaucipir PET Signal and Cognitive Change in Early Alzheimer's Disease
Not yet reported Avid Radiopharmaceuticals 205 participants Est. completion 2019-04-28 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Withdrawn NCT NCT03939780
Tau Tracer Comparison in Healthy Controls and Alzheimer's Disease Patients
Not yet reported Johns Hopkins University Est. completion 2023-04 1 site Stand-aloneOther conditions: Healthy, Alzheimer DiseaseView official trial listing → -
Completed NCT NCT04080544
Cognitive Decline and Alzheimer's Disease in the Dallas Lifespan Brain Study
Not yet reported Neil M Rofsky, MD, MHA 125 participants Est. completion 2022-06-30 1 site Stand-aloneOther conditions: Alzheimer Disease, Cognitive DeclineView official trial listing → -
Completed NCT NCT04417998
Improving PET Image Quality and Quantification by Using Motion Correction, Parametric Imaging and MAP Reconstruction
Not yet reported Mayo Clinic 80 participants Est. completion 2023-12-20 1 siteOther conditions: Brain Imaging, Whole Body ImagingView official trial listing → -
Completed NCT NCT04468347
Flortaucipir PET Imaging in the Preclinical, Prodromal and Dementia Phases of Alzheimer's Disease
Not yet reported Avid Radiopharmaceuticals 89 participants Est. completion 2018-02Other conditions: Alzheimer Disease, Mild Cognitive ImpairmentView official trial listing → -
Completed NCT NCT04474405
Exploratory Evaluation of Flortaucipir Injection in Healthy Volunteers and Cognitively Impaired Subjects
Not yet reported Avid Radiopharmaceuticals 36 participants Est. completion 2013-12-09 2 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Enrolling by invitation NCT NCT04680130
Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
Mayo Clinic 500 participants Est. completion 2050-11 1 siteOther conditions: PSP, CBD, PCA, LPA, Semantic Dementia, Semantic Aphasia, Behavioral Variant of Frontotemporal Dementia, FTD, PPA, Apraxia of Speech, MSA - Multiple System Atrophy, Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT04926259
Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders
Not yet reported First Affiliated Hospital of Fujian Medical University 50 participants Est. completion 2024-12-01 1 siteOther conditions: Neurodegenerative DisordersView official trial listing → -
Status unknown NCT NCT05326009
A Direct Comparative Study of Tau Tracer in Patients With Alzheimer's Disease
Xuanwu Hospital, Beijing 60 participants Est. completion 2023-05-31 1 siteOther conditions: Alzheimer DiseaseView official trial listing → -
Active, not recruiting NCT NCT05361382
Head-to-Head Harmonization of Tau Tracers in Alzheimer's Disease
Not yet reported Tharick Pascoal 822 participants Est. completion 2027-05-31 9 sitesOther conditions: Alzheimer DiseaseView official trial listing → -
Active, not recruiting NCT NCT05393388
Tau Pet Imaging in the Aging Brain Cohort Dedicated to Diversity Study
University of Pennsylvania 111 participants Est. completion 2027-05 1 siteOther conditions: Cognitive Decline, Alzheimer DiseaseView official trial listing → -
Enrolling by invitation NCT NCT05617014
Alzheimer's Disease Neuroimaging Initiative 4
University of Southern California 1500 participants Est. completion 2027-07-31 65 sitesOther conditions: Mild Cognitive Impairment, Alzheimer Disease, DementiaView official trial listing → -
Status unknown NCT NCT05796011
PET-CT-based Study of Central Mechanisms of Cortical Metabolism in 18F-FDG and 18F-AV1451 Age-related Deafness
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 30 participants Est. completion 2024-01-01 1 siteOther conditions: Age-related Hearing Loss, PET-CTView official trial listing → -
Enrolling by invitation NCT NCT06723015
Tau PET Outcomes With Anti-amyloid Immunotherapies
Not yet reported Mayo Clinic 135 participants Est. completion 2028-08 1 site Stand-aloneOther conditions: Cognitive Impairment, Mild, Dementia, Mild, Alzheimer DiseaseView official trial listing → -
Not yet recruiting NCT NCT07114224
Aβ PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease
Not yet reported Xijing Hospital 70 participants Est. completion 2027-06-01Other conditions: Alzheimer Disease (AD), Cognitive Dysfunction, Cognitive Disorder, PET ImagingView official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
